- Review of European marketing application for PKU now initiated -
WARREN, N.J., May 28, 2024 /PRNewswire/ PTC Therapeutics, Inc. announced today that the sepiapterin MAA for PKU has been.
- European Commission decides against adoption of negative opinion -
- Translarna authorization remains active in Europe -
- 2024 revenue guidance paused -
WARREN, N.J., May 20, 2024 /PRNewswire/ .
- European Commission decides against adoption of negative opinion Translarna authorization remains active in Europe 2024 revenue guidance paused - WARREN, N.J., May 20, 2024 /PRNewswire/
PTC Therapeutics Announces FDA Acceptance and Priority Review of the BLA for Upstaza™ prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
PTC Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.